Kazam Joshua A

CIK 000122135513 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001221355

Recent Transactions

50 trades

Exercise/Conversion
Allogene Therapeutics, Inc.$ALLO
Common Stock
2025-12-18+47,700→ 350,763 total
Exercise/Conversion
Allogene Therapeutics, Inc.$ALLO
Restricted Stock Unit
2025-12-18−47,700→ 47,700 total
Disposition to Issuer
Kronos Bio, Inc.
Stock Option (Right to Buy)
2025-06-20−34,000→ 0 total
Disposition from Tender
Kronos Bio, Inc.
Common Stock
2025-06-20$0.57/sh−94,481→ 0 total
Disposition to Issuer
Kronos Bio, Inc.
Stock Option (Right to Buy)
2025-06-20−34,000→ 0 total
Disposition to Issuer
Kronos Bio, Inc.
Stock Option (Right to Buy)
2025-06-20−34,000→ 0 total
Disposition to Issuer
Kronos Bio, Inc.
Stock Option (Right to Buy)
2025-06-20−20,600→ 0 total
Award
Allogene Therapeutics, Inc.$ALLO
Restricted Stock Unit
2025-06-18+94,500→ 94,500 total
Award
Kronos Bio, Inc.
Stock Option (Right to Buy)
2024-06-25+34,000→ 34,000 total
Award
Allogene Therapeutics, Inc.$ALLO
Stock Option (Right to buy)
2024-06-05+191,082→ 191,082 total
Award
Kronos Bio, Inc.
Stock Option (Right to Buy)
2023-06-22+34,000→ 34,000 total
Award
Allogene Therapeutics, Inc.$ALLO
Stock Option (Right to Buy)
2023-06-13+116,120→ 116,120 total
Award
Kronos Bio, Inc.
Stock Option (Right to Buy)
2022-06-22+34,000→ 34,000 total
Award
Allogene Therapeutics, Inc.$ALLO
Common Stock
2022-06-15+44,178→ 303,063 total
Gift
Kronos Bio, Inc.
Common Stock
2022-03-07−211,000→ 94,481 total
Other
Allogene Therapeutics, Inc.$ALLO
Common Stock
2022-03-07+412,618→ 671,503 total
Gift
Allogene Therapeutics, Inc.$ALLO
Common Stock
2022-03-07−412,618→ 258,885 total
Gift
Kronos Bio, Inc.
Common Stock
2022-03-07+211,000→ 305,481 total
Purchase
Allogene Therapeutics, Inc.$ALLO
Common Stock
2022-01-12$12.60/sh+15,000→ 258,885 total
Award
Kronos Bio, Inc.
Stock Option (Right to Buy)
2021-06-22+20,600→ 20,600 total
Gift
Allogene Therapeutics, Inc.$ALLO
Common Stock
2021-06-11−500,000→ 243,885 total
Award
Allogene Therapeutics, Inc.$ALLO
Common Stock
2021-06-10+16,498→ 743,885 total
Exercise/Conversion
Latch, Inc.
Class B common stock
2021-06-04−30,000→ 0 total
Exercise/Conversion
Latch, Inc.
Class A Common Stock
2021-06-04+30,000→ 30,000 total
Purchase
Tishman Speyer Innovation Corp. II
Redeemable warrants
2021-02-12+5,000→ 5,000 total
Purchase
Tishman Speyer Innovation Corp. II
Class A common stock
2021-02-12+25,000→ 25,000 total
Gift
Allogene Therapeutics, Inc.$ALLO
Common Stock
2020-10-21−305,918→ 727,387 total
Conversion
Kronos Bio, Inc.
Common Stock
2020-10-14+68,815→ 94,481 total
Conversion
Kronos Bio, Inc.
Common Stock
2020-10-14+23,556→ 25,666 total
Conversion
Kronos Bio, Inc.
Series Seed Preferred Stock
2020-10-14−22,328→ 0 total
Conversion
Kronos Bio, Inc.
Series A Preferred Stock
2020-10-14−65,228→ 0 total
Award
Allogene Therapeutics, Inc.$ALLO
Common Stock
2020-06-05+9,969→ 1,033,305 total
Other
Allogene Therapeutics, Inc.$ALLO
Common Stock
2020-04-24+8,039→ 1,023,336 total
Other
Allogene Therapeutics, Inc.$ALLO
Common Stock
2020-03-04+8,217→ 1,015,297 total
Other
DraftKings Holdings Inc.
Class B Common Stock
2019-12-31$0.00/sh+20,000→ 20,000 total
Other
Allogene Therapeutics, Inc.$ALLO
Common Stock
2019-11-19+8,217→ 1,453,703 total
Gift
Allogene Therapeutics, Inc.$ALLO
Common Stock
2019-11-11−446,623→ 1,007,080 total
Other
Allogene Therapeutics, Inc.$ALLO
Common Stock
2019-10-25+8,217→ 1,445,486 total
Other
Allogene Therapeutics, Inc.$ALLO
Common Stock
2019-09-23+8,217→ 1,437,269 total
Other
Allogene Therapeutics, Inc.$ALLO
Common Stock
2019-09-05+8,217→ 1,429,052 total
Other
Allogene Therapeutics, Inc.$ALLO
Common Stock
2019-07-18+8,217→ 1,420,835 total
Other
Allogene Therapeutics, Inc.$ALLO
Common Stock
2019-07-10+5,590→ 1,412,618 total
Award
Allogene Therapeutics, Inc.$ALLO
Common Stock
2019-06-06+16,377→ 1,407,028 total
Purchase
Target Hospitality Corp.$TH
Class A Ordinary Shares
2019-03-05$10.20/sh+5,000→ 10,000 total
Purchase
Target Hospitality Corp.$TH
Class A Ordinary Shares
2019-03-01$10.13/sh+5,000→ 5,000 total
Purchase
Target Hospitality Corp.$TH
Class B Ordinary Shares
2019-01-22$0.00/sh+20,000→ 20,000 total
Conversion
Allogene Therapeutics, Inc.$ALLO
Series A Convertible Preferred Stock
2018-10-15−3,565→ 0 total
Conversion
Allogene Therapeutics, Inc.$ALLO
Common Stock
2018-10-15+18,716→ 1,390,651 total
Award
Target Hospitality Corp.$TH
Private Placement Warrants
2018-01-17$1.50/sh+333,334→ 333,334 total
Award
CAPRICOR THERAPEUTICS, INC.$CAPR
Stock Option (right to buy)
2018-01-02+18,000→ 18,000 total

Companies

Recent Filings

Address

C/O TWO RIVER GROUP HOLDINGS, LLC 689 FIFTH AVENUE, 12TH FLOOR

NEW YORK, NY, 10022

View on SEC.gov